Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
2 of 6 columns
Comparison
| Attribute | Hepion Pharmaceuticals, Inc.8.9remove | Entera Bio Ltd.9.2remove |
|---|---|---|
| Signal scores | ||
| Radar composite | 8.9 | 9.2 |
| IPO signal score | 17.8 | 18.4 |
| Tokenization signal score | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 |
| Momentum | STABLE+5.5 | ACCELERATING+8.7 |
| Company | ||
| Stage | private | private |
| Sector | Technology | Technology |
| Headquarters | RED BANK, United States | Jerusalem |
| Founded | not on record | not on record |
| Employees | not on record | not on record |
| Capital | ||
| Latest valuation | not on record | not on record |
| Total funding | $3M | $275M |
| Latest round | Private Placement $3M | Private Placement $275M |
| Investors on record | 0 | 0 |
| Evidence | ||
| Institutional relationships | 0 | 0 |
| Active signals | 17 | 16 |
| Confidence | 59% | 56% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.